Introduction
In early April 2009, the US Centers for Disease Control and Prevention reported novel swine influenza A (H1N1) infection in two children. The virus promptly became a pandemic and caused 2500e6000 deaths.
1,2 Hemophagocytic lymphohistiocytosis (HLH) is a rare but potentially fatal disorder, characterized by a fulminant picture of nonremitting high fever, pancytopenia, hepatosplenomegaly, lymphadenopathy, liver dysfunction, coagulopathy, and neurological symptoms or encephalopathy; it can be explained by high amounts of proinflammatory cytokines such as interferon-gamma (IFN-g), interleukin (IL)-1, IL-6, and tumor necrosis factor-alpha (TNFa) resulting in the clinical characteristics of a cytokine storm. 3e5 Beutel et al 6 considered HLH associated with influenza A (H1N1) infection to be strongly associated with multiple organ failure (MOF) and death. There are very few reports of influenza-induced HLH in children. 7, 8 We report an unusual case of a rapidly progressive H1N1 infection that presented with unusual initial symptoms of fever and abdominal pain and was complicated by HLH and fatal MOF in a previously healthy 8-year-old female.
Case Report
An 8-year-old Asian female presented on September 25, 2009 with acute colicky abdominal pain, rhinorrhea, a mild cough, and a high-grade fever that had been present for 4 days. On admission, the patient was conscious and cooperative, but restless, with a core body temperature of 39. 7 C, pulse of 140 beats per minute, respiratory rate of 23 breaths per minute, and blood pressure of 90/45 mmHg. Skin examination showed no jaundice, pallor, cyanosis, rash, or purpuric lesions. There was generalized lymphadenopathy. An abdominal examination revealed a tender abdomen, and hepatosplenomegaly was noted, with the liver edge palpated at 3 cm below the right costal margin and the spleen palpated at 3 cm below the left costal margin. There were no clinically detectable ascites. The chest and cardiac examinations revealed no abnormalities. Results of the laboratory investigation are summarized in Table 1 . A chest X-ray was normal ( Figure 1A) , and abdominal ultrasonography revealed liver and spleen enlargement, gallbladder wall edema, peripancreatic retroperitoneal lymph node enlargement, and mild ascites. A computed tomography (CT) scan of the abdomen confirmed the ultrasonographic findings ( Figure 1B ). Surprisingly, bone marrow aspiration, which was performed to exclude malignancy, revealed typical hemophagocytosis ( Figure 1C) . A throat swab specimen was collected and sent for analysis for pandemic influenza A (H1N1) 2009 virus [by reverse-transcription ploymerase chain reaction (RT-PCR)]. Based on the persistent fever, hepatosplenomegaly, pancytopenia, hyperferritinemia, hypertriglyceridemia, and hemophagocytosis in the bone marrow, HLH was diagnosed. Treatment was started with rehydration, omeprazole, methylprednisolone at 30 mg/kg/dose, and intravenous immunoglobulins (IVIG) at 400 mg/kg/day.
On the 2 nd day after admission, the child was transferred to the pediatric intensive care unit due to a rapid deterioration in her general condition, persistence of fever, development of generalized tonic colonic convulsions, jaundice, multiple purpuric eruptions, oliguria, and cyanosis with a percutaneous oxygen saturation rate that dropped to 67%. At this stage, the child was ventilated mechanically. The majority of the laboratory values deteriorated, as summarized in Table 1 . That day, the patient died from MOF. Throat swab specimens were found to be positive for pandemic influenza A (H1N1) 2009 virus by RT-PCR, but unfortunately, these results were not available until after the patient died.
Discussion
HLH is a life-threatening condition caused by excessive activation and proliferation of T cells and macrophages. 9 These cellular responses can be triggered by a variety of viral, bacterial, fungal, and parasitic infections, as well as by genetic conditions, collagen-vascular diseases, and malignancies. 4 Infection-related HLH is most commonly caused by viral infections; in Taiwanese patients with infection-related HLH, mortality rates were approximately 50e60%. Despite aggressive treatment, most patient deaths resulted from refractory bleeding, pulmonary edema, and MOF. 12 In 2009, novel human influenza A (H1N1) became a pandemic, which started in Mexico and spread worldwide. The mortality rates from infections with H1N1 were higher in patients who developed HLH and MOF.
The clinical presentation of HLH is usually acute and can be dramatic, causing fatalities. Typically, most clinical features and laboratory findings can be explained by the widespread dissemination of hyperactivated lymphocytes and macrophages, and are compatible with the biologic effects of several T-lymphocyte-and macrophage-derived proinflammatory cytokines, such as IFN-g, IL-1, IL-6, and TNF-a. 3 According to the guidelines of the International Histiocyte Society, the diagnosis of HLH requires the presence of at least five of the following eight criteria: fever, splenomegaly, cytopenias, hypertriglyceridemia and/or hypofibrinogenemia, hyperferritinemia, elevated soluble IL-2 receptor alpha (IL-2Ra) levels, decreased or absent natural killer (NK) cell activity, and hemophagocytosis in the bone marrow, spleen, or lymph nodes. 13 In our case, diagnosis was based on the presence of five of these criteria.
Our patient had an abnormal presentation, with fever and colicky abdominal pain. Willekens et al 14 described a patient with fulminant HLH induced by pandemic A (H1N1) influenza who also presented with predominantly digestive symptoms.
The child in our case developed dramatic and severe HLH and lethal MOF on the 2 nd day after hospital admission. The mechanisms leading to HLH, MOF, and death in patients infected with influenza are not yet well understood. Uncontrolled dissemination of the virus, with a parallel excessive inflammatory reaction, causes extensive and disseminated tissue damage, which damages the lungs, liver, and brain. 15 More specifically, a "cytokine storm", along with elevated plasma levels of sIL-2R and other inflammatory mediators, and an accumulation of activated Tlymphocytes and macrophages in various organs, frequently results in MOF and death.
Several treatment options for HLH have been reported, with the immediate aim of suppressing uncontrolled hyperinflammation with immunosuppressive/immunomodulatory agents or cytotoxic drugs. As in our case, IVIG is one of the options for treatment of severe life-threatening virusassociated hemophagocytic syndrome (VAHS). The dosage and duration of IVIG therapy ranges from 400 mg/kg/day for 5 days to 1 g/kg/day for 2 days. 16 In our case, a combination of IVIG and methylprednisolone failed to prevent the death of the child. Effective treatment of HLH with cyclosporine, intravenous cyclophosphamide, and an IL-1 receptor antagonist has been demonstrated in reported cases.
Early diagnosis of VAHS is a clinical challenge that requires a high index of suspicion. The diagnosis is often delayed due to a variety of factors, including the rarity of HLH, the complexity of the diagnostic criteria, and concerns regarding the specificity of the current diagnostic criteria.
One hypothesis is that early treatment with antiviral drugs may improve survival in patients with VAHS-associated influenza A (H5N1) virus infection. 17 Ozdemir et al 8 reported
successful treatment with peroral oseltamivir in a patient with HLH after infection with influenza A (H1N1) virus. Very recently, Asai et al 18 reported a case of severe influenza A (H1N1) pneumonia complicated with VAHS that was successfully treated using a combination of steroid pulse, erythromycin IV, and anti-influenza drugs. Introduction of antiviral agents in some cases of viral-induced HLH was associated with a better clinical outcome. 19, 20 The failure to introduce anti-influenza drugs in our case may be due to the fulminant course of HLH and the very rapid deterioration of the patient's condition.
In conclusion, HLH with MOF is a very rare condition that can be induced by the novel H1N1 influenza variant. It may have an unusual initial presentation and follow a very aggressive and fatal course. Physicians should be aware of this possibility to allow for early recognition and treatment.
